CLINICAL SIGNIFICANCE OF NT-PROBNP, NEPHROLOGICAL AND INFLAMMATORY BIOMARKERS IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE

Authors

  • Kurbanov N.B., Tulaboyeva G.M., Khan Mutasim Billah, Talipova Yu.Sh., Sagatova Kh.M., Abdukadirova N.M., Khusanov A.A. Center for the Development of Professional Qualification of Medical Workers Author

Keywords:

CHF, NT-proBNP, urea, creatinine, CRP, eGFR

Abstract

In 185 elderly patients with CHF, the relationship between NT-proBNP and nephro-inflammatory biomarkers was analyzed. NT-proBNP levels showed positive correlations with urea, creatinine, CRP, and a negative correlation with eGFR. The findings confirm the involvement of complex cardio-renal and inflammatory mechanisms.

References

1.McDonagh T.A., Metra M., Adamo M., et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal. 2021;42(36):3599–3726.

2.Yancy C.W., Jessup M., Bozkurt B., et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure. Circulation. 2017;136(6):e137–e161.

3.Ponikowski P., Voors A.A., Anker S.D., et al. Heart failure: preventing disease and death worldwide. European Heart Journal. 2014;35(7):415–426.

4.Volpe M., Rubattu S., Burnett J. Natriuretic peptides in cardiovascular diseases: current use and perspectives. European Heart Journal. 2014;35(7):419–425.

5.Ronco C., McCullough P., Anker S.D., et al. Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative. European Heart Journal. 2010;31(6):703–711.

6.Kalogeropoulos A.P., Georgiopoulou V.V., Butler J. Clinical adoption of prognostic biomarkers: the case for NT-proBNP in heart failure. Heart Failure Reviews. 2010;15(3):243–252.

Downloads

Published

2026-05-17